457 related articles for article (PubMed ID: 9078279)
1. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein.
Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):317-25. PubMed ID: 9078279
[TBL] [Abstract][Full Text] [Related]
2. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions.
Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Thorpe SR
Nephrol Dial Transplant; 1996; 11 Suppl 5():48-53. PubMed ID: 9044307
[TBL] [Abstract][Full Text] [Related]
3. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
[TBL] [Abstract][Full Text] [Related]
4. Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation.
Malle E; Ibovnik A; Leis HJ; Kostner GM; Verhallen PF; Sattler W
Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):377-84. PubMed ID: 7749848
[TBL] [Abstract][Full Text] [Related]
5. Protein modification by lipid peroxidation products: formation of malondialdehyde-derived N(epsilon)-(2-propenol)lysine in proteins.
Uchida K; Sakai K; Itakura K; Osawa T; Toyokuni S
Arch Biochem Biophys; 1997 Oct; 346(1):45-52. PubMed ID: 9328283
[TBL] [Abstract][Full Text] [Related]
6. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
Palinski W; Ylä-Herttuala S; Rosenfeld ME; Butler SW; Socher SA; Parthasarathy S; Curtiss LK; Witztum JL
Arteriosclerosis; 1990; 10(3):325-35. PubMed ID: 1693068
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1.
Greilberger J; Jürgens G
Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):185-91. PubMed ID: 9512478
[TBL] [Abstract][Full Text] [Related]
8. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts.
Hartley DP; Kroll DJ; Petersen DR
Chem Res Toxicol; 1997 Aug; 10(8):895-905. PubMed ID: 9282839
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional changes in LDL after modification with both 4-hydroxynonenal and malondialdehyde.
Hoff HF; O'Neil J
J Lipid Res; 1993 Jul; 34(7):1209-17. PubMed ID: 8371068
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies.
Virella G; Koskinen S; Krings G; Onorato JM; Thorpe SR; Lopes-Virella M
Clin Immunol; 2000 May; 95(2):135-44. PubMed ID: 10779407
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of acrolein-specific adducts generated during lipid peroxidation-modification of proteins in vitro: identification of N(τ)-(3-propanal)histidine as the major adduct.
Maeshima T; Honda K; Chikazawa M; Shibata T; Kawai Y; Akagawa M; Uchida K
Chem Res Toxicol; 2012 Jul; 25(7):1384-92. PubMed ID: 22716039
[TBL] [Abstract][Full Text] [Related]
12. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload.
Houglum K; Filip M; Witztum JL; Chojkier M
J Clin Invest; 1990 Dec; 86(6):1991-8. PubMed ID: 2123889
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometric evidence of malonaldehyde and 4-hydroxynonenal adductions to radical-scavenging soy peptides.
Zhao J; Chen J; Zhu H; Xiong YL
J Agric Food Chem; 2012 Sep; 60(38):9727-36. PubMed ID: 22946674
[TBL] [Abstract][Full Text] [Related]
14. Protein adducts generated from products of lipid oxidation: focus on HNE and one.
Sayre LM; Lin D; Yuan Q; Zhu X; Tang X
Drug Metab Rev; 2006; 38(4):651-75. PubMed ID: 17145694
[TBL] [Abstract][Full Text] [Related]
15. Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis.
Sakata N; Uesugi N; Takebayashi S; Nagai R; Jono T; Horiuchi S; Takeya M; Itabe H; Takano T; Myint T; Taniguchi N
Cardiovasc Res; 2001 Feb; 49(2):466-75. PubMed ID: 11164857
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions.
Hazen SL; Gaut JP; Crowley JR; Hsu FF; Heinecke JW
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):693-9. PubMed ID: 11104675
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein has an enormous capacity to bind (E)-4-hydroxynon-2-enal (HNE): detection and characterization of lysyl and histidyl adducts containing multiple molecules of HNE.
Annangudi SP; Deng Y; Gu X; Zhang W; Crabb JW; Salomon RG
Chem Res Toxicol; 2008 Jul; 21(7):1384-95. PubMed ID: 18570390
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry-based proteomics of oxidative stress: Identification of 4-hydroxy-2-nonenal (HNE) adducts of amino acids using lysozyme and bovine serum albumin as model proteins.
Aslebagh R; Pfeffer BA; Fliesler SJ; Darie CC
Electrophoresis; 2016 Oct; 37(20):2615-2623. PubMed ID: 27184861
[TBL] [Abstract][Full Text] [Related]
19. Formation of malondialdehyde adducts in livers of rats exposed to ethanol: role in ethanol-mediated inhibition of cytochrome c oxidase.
Chen J; Petersen DR; Schenker S; Henderson GI
Alcohol Clin Exp Res; 2000 Apr; 24(4):544-52. PubMed ID: 10798592
[TBL] [Abstract][Full Text] [Related]
20. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
Sakata N; Moh A; Takebayashi S
Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
